Researchers from the Second Affiliated Hospital of Nanjing Medical University, et al. have published a case report entitled ...

PARIS--(BUSINESS WIRE)--TheraVectys, a biotechnology company that designs and develops lentiviral vector-based vaccines and immunotherapies against infectious agents and cancers, announces that the ...

For the past few years, SARS-CoV-2 and mRNA-based vaccines have dominated the scientific and clinical work on infectious diseases, but other diseases and vaccine approaches are attracting attention.

New research led by Flinders University and international experts is expanding understanding of vaccine-induced immune thrombocytopenia and thrombosis (known as VITT). At the height of the COVID-19 ...

Vaccine strategies for the treatment of prostate cancer are under active investigation, using a wide variety of approaches including whole-tumor-cell vaccines, DC approaches and vector-driven delivery ...

Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...

This letter to the editor presents an in-depth overview of the current state of Nipah virus (NiV) vaccine development, highlighting both scientific advancements and critical challenges that still ...